Prevention and control of rheumatic heart disease: Overcoming core challenges in resource-poor environments
- PMID: 29440834
- PMCID: PMC5803981
- DOI: 10.4103/apc.APC_135_17
Prevention and control of rheumatic heart disease: Overcoming core challenges in resource-poor environments
Abstract
Rheumatic heart disease (RHD) has long receded as a significant threat to public health in high-income countries. In low-resource settings, however, the specter of RHD remains unabated, as exemplified by recent data from the Global Burden of Diseases Study. There are many complex reasons for this ongoing global disparity, including inadequate data on disease burden, challenges in effective advocacy, ongoing poverty and inequality, and weak health systems, most of which predominantly affect developing nations. In this review, we discuss how each of these acts as a core challenge in RHD prevention and control. We then examine key lessons learnt from successful control programs in the past and highlight resources that have been developed to help create strong national RHD control programs.
Keywords: Control; developing countries; prevention; rheumatic heart disease.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Impact of Socio-Economic Factors on Increased Risk and Progression of Rheumatic Heart Disease in Developing Nations.Curr Infect Dis Rep. 2019 May 1;21(6):21. doi: 10.1007/s11908-019-0677-6. Curr Infect Dis Rep. 2019. PMID: 31044281 Review.
-
Time to tackle rheumatic heart disease: Data needed to drive global policy dialogues.Glob Public Health. 2018 Sep 7:1-13. doi: 10.1080/17441692.2018.1515970. Online ahead of print. Glob Public Health. 2018. PMID: 30192707
-
Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?Curr Opin Pediatr. 2015 Feb;27(1):116-23. doi: 10.1097/MOP.0000000000000164. Curr Opin Pediatr. 2015. PMID: 25490689 Review.
-
Rheumatic Heart Disease: The Unfinished Global Agenda.Cardiol Clin. 2017 Feb;35(1):165-180. doi: 10.1016/j.ccl.2016.08.006. Cardiol Clin. 2017. PMID: 27886787 Review.
-
Societies of Futures Past: Examining the History and Potential of International Society Collaborations in Addressing the Burden of Rheumatic Heart Disease in the Developing World.Front Cardiovasc Med. 2021 Nov 2;8:740745. doi: 10.3389/fcvm.2021.740745. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34796211 Free PMC article.
Cited by
-
Temporal Trends and Burden of Rheumatic Heart Disease in South Asia: A Comprehensive Analysis of Three Decades from Global Burden of Disease Study.Glob Heart. 2024 Jun 26;19(1):53. doi: 10.5334/gh.1336. eCollection 2024. Glob Heart. 2024. PMID: 38947253 Free PMC article.
-
Outcomes of rheumatic fever in Uganda: a prospective cohort study.Lancet Glob Health. 2024 Mar;12(3):e500-e508. doi: 10.1016/S2214-109X(23)00567-3. Lancet Glob Health. 2024. PMID: 38365420 Free PMC article.
-
Trends in Deaths from Rheumatic Heart Disease in the Eastern Mediterranean Region: Burden and Challenges.J Cardiovasc Dev Dis. 2018 May 30;5(2):32. doi: 10.3390/jcdd5020032. J Cardiovasc Dev Dis. 2018. PMID: 29848951 Free PMC article.
-
The roles of immuno-modulator treatment and echocardiographic screening in rheumatic fever and rheumatic heart disease control: research from Aotearoa, New Zealand.J R Soc N Z. 2024 Feb 7;55(2):241-266. doi: 10.1080/03036758.2024.2306981. eCollection 2025. J R Soc N Z. 2024. PMID: 39677380 Free PMC article. Review.
-
Matrix metalloproteinase-9 in pediatric rheumatic heart disease with and without heart failure.Biomed Rep. 2021 Jan;14(1):4. doi: 10.3892/br.2020.1380. Epub 2020 Oct 23. Biomed Rep. 2021. PMID: 33240496 Free PMC article.
References
-
- Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, et al. Global, regional, and national burden of rheumatic heart disease, 1990-2015. N Engl J Med. 2017;377:713–22. - PubMed
-
- Robertson KA, Mayosi BM. Rheumatic heart disease: Social and economic dimensions. S Afr Med J. 2008;98:780–1. - PubMed
-
- Maurice J. Rheumatic heart disease back in the limelight. Lancet. 2013;382:1085–6. - PubMed
-
- Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509–38. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous